MGNX vs SPG · rev $39.6M vs rev $3.55B
MacroGenics Inc (MGNX) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
SPG (SPG) common stock.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
MGNX currently screens at market cap $246.6M. SPG currently screens at market cap $0.
Not investment advice. Open the MGNX and SPG stock pages for the full models.
Not investment advice.